Upneeq
Upneeq

The only FDA-approved prescription eye drop for low-lying lids

The only FDA-approved prescription eye drop for low-lying lids​

Freshen up those eyes!

Upneeq® prescription eye drop helps target acquired ptosis (low-lying eyelids). Upneeq® stimulates Muller’s muscle – a muscle that maintains elevation of the upper eyelid. Using Upneeq® just once per day has been found to deliver a rapid, visible lift to the upper eyelid that not only improves appearance, but also helps improve vision.

How Does Acquired Ptosis Affect You?

In addition to affecting your appearance, low-lying eyelid(s) can also impact your eyesight by reducing your field of vision. This issue can cause a hindrance in daily activity and physical appearance: 

Low-lying eyelids can be caused by numerous physical changes in your appearance including due to aging, underlying medical conditions, congenital issues and prior eye surgeries. 

Acquired ptosis can occur in all ages. This condition contributes to delayed day to day functioning. Overtime, it can become challenging to do basic daily activities as it can block and/or lower your field of vision. 

FAQ's

UPNEEQ® (oxymetazoline hydrochloride ophthalmic solution), 0.1% is a prescription eyedrop used to treat low-lying lids (acquired blepharoptosis) in adults.

Your Upneeq prescription comes with 45 single use droppers, that will last 45 days when used daily. Your Upneeq prescription comes with 45 single use droppers, that will last 45 days when used daily.

The most common adverse reactions with UPNEEQ® (occurring in 1-5% of patients) were eye inflammation, eye redness.

In the trial, the onset of the drop was statistically significant at 15 minutes, although many patients responded as early as 5 minutes.

OUR REVIEWS

We are here to help

Schedule a consultation now!